Transdermal Drug Delivery System Market to Grow at 14.4% CAGR Through 2032 According to a newly published market research report by 24LifeSciences, global transdermal drug delivery system market was valued at USD 17,620 million in 2024 and is projected to reach USD 44,230 million by 2031, growing at a compound annual growth rate (CAGR) of 14.4% during the forecast period 2025–2031. Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/7855/transdermal-drug-delivery-system-market

Gene Delivery Technologies Market 2024 Industry Analysis, History, Overviews, Value, Supply, and Forecast 2034 The global Gene Delivery Technologies Market is undergoing rapid expansion, driven by the increasing demand for advanced genetic therapies and precision medicine. The market is projected to grow from USD 5.20 billion in 2024 to USD 14.30 billion by 2034, registering a strong CAGR of 11.90% over the forecast period. This growth reflects the rising importance of gene-based treatment approaches in modern healthcare. To receive a PDF sample of the report, visit @ https://www.emergenresearch.com/request-free-sample/4288

Prefilled Plastic Syringes Market to Grow at 4.7% CAGR Through 2032 According to a newly published market research report by 24LifeSciences, global prefilled plastic syringes market was valued at USD 904 million in 2024 and is projected to reach USD 1,234 million by 2032, growing at a compound annual growth rate (CAGR) of 4.7% during the forecast period. Prefilled plastic syringes are innovative drug delivery systems designed for precise and convenient administration of medications. These syringes come pre-filled with a measured dose of liquid drugs, typically made from durable plastic materials such as polypropylene or cyclic olefin copolymers, offering significant advantages like reduced breakage risk compared to glass alternatives. They support various applications in parenteral drug delivery, including vaccines, biologics, and insulin, ensuring sterility and ease of use for both healthcare providers and patients. The growing demand is largely driven by the rising prevalence of chronic diseases, increasing adoption of self-administration therapies, and continuous advancements in pharmaceutical manufacturing technologies. Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/767/prefilled-plastic-syringes-market-market

The HIV Diagnostics Market is a core segment of the global infectious disease diagnostics industry, focused on the detection, confirmation, and monitoring of HIV infection across screening, diagnosis, treatment initiation, early infant diagnosis, and long-term care pathways. The market serves hospitals, central laboratories, blood banks, public health testing programs, antenatal clinics, community testing networks, pharmacies, and increasingly home-based consumer channels. Key applications include routine screening, diagnosis of acute infection, confirmatory testing after an initial reactive result, testing to support prevention services, infant testing in exposed newborns, and viral load monitoring in treated patients. Recent trends show a clear shift from antibody-only approaches toward a broader mix of lab-based antigen/antibody assays, rapid point-of-care formats, nucleic acid testing for earlier detection, and self-testing models that improve convenience and reach. The category is also moving toward more differentiated service delivery, with stronger integration of facility-based, community-based, and self-directed testing pathways.